Changes in SGOT activity during treatment with ethionamide.
D001219:Aspartate Aminotransferases / Q000097:blood*; D056486:Chemical and Drug Induced Liver Injury / Q000201:enzymology*; D005000:Ethionamide / Q000009:adverse effects*; D005260:Female; D006801:Humans; D008111:Liver Function Tests; D008297:Male; D009536:Niacinamide / Q000627:therapeutic use; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy* / Q000201:enzymology
D009536:Niacinamide; D001219:Aspartate Aminotransferases; D005000:Ethionamide